Federal Trade Commission (FTC) pursued the ACAM, an organization that promotes "complementary, alternative and integrative medicine" over the claims made regarding the treatment of atherosclerosis in advertisements for EDTA chelation therapy
Mahmoud et al
Read More FDA Press Statement || FDA Actively Participates During the 2025 USP Convention 3 June 2025 Washington D.C., U.S.A
Chelation therapy removes harmful metals from the body
Chen W, Fan D, Meng L, Miao Y, Yang S, Weng Y, He H, Tang X
Selected Data 1) This study conducted by the research team of Khavinson et al aimed to evaluate the mesenchymal and neurogenic differentiation potential of human gingival mesenchymal stem cells (hGMSCs), particularly following treatment with the synthetic tetrapeptide Epitalon